Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming
normal tissue.
PURPOSE: Phase I trial to study the effectiveness of boron neuron capture therapy in treating
patients with stage III melanoma.